Continued strong sales and net income growth - Fresenius fully confirms 2013 outlook(lifePR) ( Bad Homburg, )
Sales €15.0 billion (+9% in constant currency, +7% at actual rates)
EBIT1 €2.2 billion, (+1% in constant currency, -1% at actual rates)
Net income2 €753 million (+12% in constant currency, +10% at actual rates)
Ulf Mark Schneider, CEO of Fresenius, said: "Fresenius had yet another outstanding quarter, posting the highest quarterly earnings in the company's history. We also made significant progress regarding the Group's strategic posture. Our landmark acquisition of 43 hospitals from Rhön-Klinikum AG will enable us to build a hospital network across Germany offering innovative approaches to health care."
Group outlook 2013 fully confirmed
Based on the Group's strong financial results in the first three quarters, Fresenius fully confirms its guidance for 2013. Sales are expected to increase by 7% to 10% and net income1 is expected to increase by 11% to 14% (both in constant currency).
The Group plans to invest around 5% of sales in property, plant and equipment.
On September 13, 2013, Fresenius announced the acquisition of 43 hospitals from Rhön- Klinikum AG. The vast majority of the transaction is expected to close by the end of this year. The purchase price of €3.07 billion will be entirely debt-financed. The pro forma Group net debt/EBITDA is expected to temporarily exceed 3.0 in 2013 but remain below 3.5, before returning to the upper end of the 2.5 to 3.0 target range in 2014.
For more information see attachment!